SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus / COVID-19 Pandemic -- Ignore unavailable to you. Want to Upgrade?


To: Glenn Petersen who wrote (21501)10/24/2022 6:22:48 PM
From: KCzeslawZ2 Recommendations

Recommended By
Investor2
Stormwatch17

  Read Replies (2) | Respond to of 22868
 
It’s interesting how all these studies of ivermectin under dose. This would like giving 1/2 the dosage of Paxlovid for 2 or 3 days or giving one shot of the Covid vaccine. Both of these would fail the trials as well. At 64 yo, & 97kgs (27 BMI) I took 0.6/Kg or 60mgs for 7 days and was back to my old self after 8 or 9 days. But maybe it’s just the genes I was born with.



To: Glenn Petersen who wrote (21501)10/24/2022 7:50:45 PM
From: Investor22 Recommendations

Recommended By
KCzeslawZ
Stormwatch17

  Respond to of 22868
 
Ivermectin, a drug once touted by conservatives as a treatment for Covid,...
That's a very strange statement. "Ivermectin, a drug touted by some doctors as a treatment for Covid,..." seems more appropriate.

Best wishes,

I2



To: Glenn Petersen who wrote (21501)10/25/2022 8:05:21 AM
From: Sam2 Recommendations

Recommended By
Glenn Petersen
oldbeachlvr

  Read Replies (4) | Respond to of 22868
 
Here is MedPage Today's story on that ivermectin study.

Ivermectin: Still on a Losing Streak as COVID-19 Treatment — ACTIV-6 trial shows no time-to-recovery benefit with anti-parasitic in mild-to-moderate disease
by Ed Susman, Contributing Writer, MedPage Today

October 22, 2022

medpagetoday.com